(Q34572035)

3 August 2017

1 reference

title

Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs (English)

1 reference

3 August 2017

1 reference

1

1 reference

3 August 2017

G Gasparini

2

1 reference

3 August 2017

A L Harris

series ordinal

3

1 reference

3 August 2017

publication date

1 May 2001

1 reference

Lancet Oncology Commission

3 August 2017

published in

1 reference

3 August 2017

volume

2

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

278-289

1 reference

What Is the Evidence That Tumors Are Angiogenesis Dependent?

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Halting angiogenesis suppresses carcinoma cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Angiogenesis as a marker of preneoplastic lesions of the human breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Delivery of molecular and cellular medicine to solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Genes expressed in human tumor endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Involvement of platelets in tumour angiogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Isolation of a tumor factor responsible for angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Angiopoietin-1 induces sprouting angiogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Antiangiogenic activity of the cleaved conformation of the serpin antithrombin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Interferon alfa-2a therapy for life-threatening hemangiomas of infancy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Association of Tumor Angiogenesis With Bone Marrow Micrometastases in Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Association of Angiogenesis in Lymph Node Metastases With Outcome of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Correlation of Vascular Endothelial Growth Factor Content With Recurrences, Survival, and First Relapse Site in Primary Node-Positive Breast Carcinoma After Adjuvant Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Immunocytochemical markers in stage I lung cancer: relevance to prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Serum Soluble Vascular Cell Adhesion Molecule-1: Role as a Surrogate Marker of Angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

The role of cyclooxygenases in inflammation, cancer, and development

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900323-5

7 January 2021

10.1016/S1470-2045(00)00323-5

Identifiers

DOI

1 reference

3 August 2017

1 reference